Cybin Inc.

NEO: CYBN


Canadian symbol: CYBN.NE
US symbol: CLXPF

Currency in CAD

Valuation Measures

Market Cap (intraday) 5269.08M
Enterprise Value 398M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)4.78
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3105.32%
S&P500 52-Week Change 343.61%
52 Week High 32.6000
52 Week Low 30.6400
50-Day Moving Average 31.7583
200-Day Moving Average 31.7075

Share Statistics

Avg Vol (3 month) 3654.57k
Avg Vol (10 day) 3401.74k
Shares Outstanding 5140.14M
Implied Shares Outstanding 6N/A
Float 112.95M
% Held by Insiders 14.10%
% Held by Institutions 12.72%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar. 30, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-1.94M
Diluted EPS (ttm)-0.2590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)40.03M
Total Cash Per Share (mrq)0.27
Total Debt (mrq)107.41k
Total Debt/Equity (mrq)0.20
Current Ratio (mrq)6.24
Book Value Per Share (mrq)0.40

Cash Flow Statement

Operating Cash Flow (ttm)-1.39M
Levered Free Cash Flow (ttm)N/A

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Psychedelics News and Psilocybin Investing

Real-time news from hundreds of sources. Never miss the news that matters the most.




Company News Date
CYBN.NE
Cybin
1 month ago
CYBN.NE
Cybin
1 month ago
CYBN.NE
Cybin
2 months ago
CYBN.NE
Cybin
2 months ago
CYBN.NE
Cybin
3 months ago
CYBN.NE
Cybin
3 months ago
CYBN.NE
Cybin
3 months ago
CYBN.NE
Cybin
4 months ago
CYBN.NE
Cybin
4 months ago
CYBN.NE
Cybin
4 months ago
CYBN.NE
Cybin
4 months ago
CYBN.NE
Cybin
4 months ago
CYBN.NE
Cybin
4 months ago
CYBN.NE
Cybin
4 months ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
4.10%% of Shares Held by All Insider
2.72%% of Shares Held by Institutions
2.84%% of Float Held by Institutions
4Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Cybin Inc.


Media Advisory – Presentation of the round table on the theme “First Nations and the Economic Development”

TORONTO, Jan. 15, 2021 - Trading resumes in:Company: CYBIN INC.NEO Exchange Symbol: CYBNAll Issues: NoResumption (ET): 10:21:58 AMIIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national ... Read More...

Pontus Announces Acquisition of Ephémère Supper Club to Vertically Integrate Product Development

VANCOUVER, BC, Feb. 17, 2021 - Pontus Protein Ltd. ("Pontus" or the "Company") (TSXV: HULK) (FSE: 8YC) is pleased to announce that it has entered into a definitive agreement dated February 16, 2021 (the "Definitive Agreement") to acquire all of the issued and outstanding shares of Ephemere Catering & Consulting Inc. ("Ephémère").Ephém... Read More...

Rogers Cybersecure Catalyst at Ryerson University Announces the Launch of the Catalyst Cyber Range

The Catalyst Cyber Range is a state-of-the-art cybersecurity training and testing platform that will train new cybersecurity workers, upskill existing cybersecurity professionals, and drive cybersecurity research and innovation in CanadaBRAMPTON, ON, Feb. 11, 2021 - Rogers Cybersecure Catalyst at Ryerson University is pleased to announce ... Read More...

Cybin Included in First Psychedelic Exchange Traded Fund

– Horizons Psychedelic Stock Index ETF Index now trading on the NEO Exchange –Not for distribution to the U.S. news wire services or dissemination in the United StatesCybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it is among the select compan... Read More...

Cybin Announces CDN$20 Million Bought Deal Offering

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TORONTO, Jan. 18, 2021 - Cybin Inc. (NEO: CYBN) ("Cybin" or the "Company"), a life sciences company focused on psychedelic pharmaceutical therapies, is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. ("... Read More...

Cybin Announces API Synthesis of Multiple Tryptamine Derivatives Based on the First Milestone Achievement Pursuant to the Adelia Acquisition

Cybin Inc. (NEO:CYBN) ("Cybin" or the "Company"), a life sciences company focused on psychedelic therapeutics, is pleased to announce that Adelia Therapeutics Inc. ("Adelia"), a wholly-controlled subsidiary of Cybin, has achieved the earn-out milestones for the period commencing November 15, 2020, as contemplated by the terms of a contrib... Read More...

Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics

HIGHLIGHTSUsing Kernel’s technology, Cybin will be able to quantify brain activity in real time during psychedelic experiences. The absence of this data has been a limitation in the progression of new molecules targeting neurological disorders.Kernel’s technology opens new frontier in psychedelic therapeutics by acquiring longitudinal bra... Read More...

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics as Part of its Commitment to Strategic Growth

Cybin to host conference call today, December 7, 2020, at 5:00 p.m. ETTransaction adds extensive intellectual property portfolio and product pipeline to potentially diversify Cybin’s programs and includes multiple additional indications.Adelia brings a range of technologies related to novel therapeutics, delivery methods, and therapeutic ... Read More...

Cybin Goes Public on NEO Exchange

NEO is excited to announce that Cybin Inc. ("Cybin" or the "Company"), a leading Toronto-based biotech and life sciences company focused on psychedelic pharmaceutical therapies, has made its debut on the global public markets today. Cybin is now trading on the NEO Exchange under the symbol NEO:CYBN.This press release features multimedia. ... Read More...
Coming Soon.

Delayed data (1h)


Share this page